The conversation around regenerative medicine in India has taken a sharp turn. The Supreme Court recently delivered a landmark ruling barring stem cell therapy as a treatment for Autism Spectrum ...

Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new ...

Gene therapy provides more quality-adjusted life-years versus non-myeloablative haploidentical allogeneic stem cell transplantation in sickle cell disease, but at a much higher cost. The cost of gene ...

A phase 2b study of Longeveron’s stem cell therapy in a pediatric heart disease has missed its primary endpoint, prompting ...